14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 BLUE stock ended at $1.00. This is 11.14% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 22.21% from a day low at $0.85 to a day high of $1.04.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical bluebird bio prices

Date Open High Low Close Volume
Feb 23, 2023 $5.41 $5.44 $5.16 $5.28 2 670 768
Feb 22, 2023 $5.24 $5.39 $5.22 $5.38 2 872 001
Feb 21, 2023 $5.56 $5.62 $5.18 $5.21 2 968 246
Feb 17, 2023 $5.64 $5.69 $5.49 $5.69 3 012 024
Feb 16, 2023 $5.85 $5.86 $5.60 $5.64 3 518 712
Feb 15, 2023 $5.88 $5.95 $5.73 $5.94 2 837 697
Feb 14, 2023 $5.90 $6.02 $5.76 $5.93 2 713 906
Feb 13, 2023 $5.84 $6.03 $5.73 $5.96 2 601 173
Feb 10, 2023 $6.01 $6.07 $5.87 $5.92 2 625 040
Feb 09, 2023 $6.26 $6.34 $6.03 $6.08 2 534 074
Feb 08, 2023 $6.66 $6.66 $6.21 $6.24 2 572 425
Feb 07, 2023 $6.67 $6.75 $6.54 $6.69 2 229 285
Feb 06, 2023 $6.66 $6.68 $6.48 $6.66 1 816 322
Feb 03, 2023 $6.40 $6.82 $6.37 $6.65 3 007 011
Feb 02, 2023 $6.50 $6.73 $6.28 $6.63 4 784 365
Feb 01, 2023 $6.34 $6.48 $6.14 $6.38 2 894 469
Jan 31, 2023 $6.15 $6.42 $6.15 $6.35 3 245 111
Jan 30, 2023 $6.15 $6.21 $6.00 $6.11 3 207 364
Jan 27, 2023 $6.20 $6.50 $6.15 $6.28 2 666 685
Jan 26, 2023 $6.31 $6.35 $6.07 $6.23 3 313 885
Jan 25, 2023 $6.37 $6.44 $6.20 $6.33 2 153 153
Jan 24, 2023 $6.16 $6.60 $6.16 $6.53 4 484 488
Jan 23, 2023 $6.24 $6.42 $6.03 $6.19 5 415 365
Jan 20, 2023 $5.93 $6.30 $5.68 $6.20 6 888 021
Jan 19, 2023 $6.14 $6.19 $5.87 $5.92 11 616 406
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT